Since previous studies using the overexpression of murine Sdc-1 in human breast cancer cells provided insights into its role in cell-cycle progression [24], we performed cell cycle analysis for Sdc-1-overexpressing cells with respect to TFPI treatment. The gene discussed is SDC1; the disease is breast carcinoma.